JEFFREY DODD-O, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD

License number

Maryland D45275

Personal information

See more information about JEFFREY DODD-O at radaris.com

Name

Address

Phone

Jeffrey M Dodd-O

13231 Greenbank Rd, Middle River, MD 21220

(410) 335-5728

Jeffrey M Dodd-O

1327 W 41St St, Baltimore, MD 21211

(410) 235-1526

Organization information

See more information about JEFFREY DODD-O at bizstanding.com

Jeffrey Dodd-O MD

600 N Wolfe St, Baltimore, MD 21287

Industry:

Anesthesiology, Obgyn

Phone:

(410) 955-9080 (Phone)

Jeffrey Michael Dodd-O

Professional information

Jeffrey M Dodd-O, Baltimore MD

Specialties:

Anesthesiologist

Address:

600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe, Baltimore, MD 21287

Board certifications:

American Board of Anesthesiology Certification in Anesthesiology, American Board of Anesthesiology Sub-certificate in Critical Care Medicine (Anesthesiology)

Dr. Jeffrey Dodd-O, Baltimore MD - MD (Doctor of Medicine)

Specialties:

Critical Care Medicine

Address:

JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)

Certifications:

Anesthesiology, 1994, Critical Care Medicine, 1997

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287

Education:

Medical School
Medical College of Pennsylvania
Youngstown Hospital
Graduated: 1986
Johns Hopkins Hospital
Graduated: 1993
Graduated: 1994

Use Of An Nadph-Oxidase Inhibitor In The Treatment Of Reperfusion Injury

US Patent:

6090851, Jul 18, 2000

Filed:

Sep 9, 1998

Appl. No.:

9/150069

Inventors:

Jeffrey M. Dodd-o - Baltimore MD
David B. Pearse - Ellicott City MD

Assignee:

Johns Hopkins University School of Medicine - Baltimore MD

International Classification:

A61K 3119, A61K 3112, A61K 3111, A61K 31075, A61K 3105

US Classification:

514568

Abstract:

The present invention is directed to a method for the prophylactic and therapeutic treatment of reperfusion injury or injury due to a distal reperfusion. The method involves the administration of an NADPH-oxidase inhibitor to a cell, tissue, organ or animal in an amount sufficient to treat the cell, tissue, organ or animal for reperfusion injury prophylactically or therapeutically. The NADPH-oxidase inhibitor preferably is an o-methoxycatechol, or a pharmaceutically acceptable salt, derivative, dimer or prodrug thereof. Most preferably, the o-methoxycatechol is apocynin.